Analytics: Approaches in quality assurance and quality control used in pharmaceutical development and manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Analytics
Analytical testing methods in pharma manufacturing. Chromatography, UHPLC, chiral. Near-infrared (NIR) and Raman spectroscopy. Anticounterfeiting. Dissolution testing. Cleaning validation. Extractables & leachables.

Elemental Impurity Analysis

August 2, 2012

Pharmaceutical Technology

The author discusses how to manage pending pharmacopeial changes.

Technology Fights Back

August 2, 2012

Pharmaceutical Technology

Meticulous system configuration can prevent machines from taking over.

A Statistical Review of ICH Q10 Pharmaceutical Quality System

August 2, 2012

Pharmaceutical Technology

Applying the recommendations of ICH Q10 to statistical analysis can help prevent product recalls.

In the Spotlight

August 2, 2012
Pharmaceutical Technology

New product reviews for August 2012.

Analytical Tools for a Quality-by-Design Approach to Lyophilization

July 18, 2012

Equipment and Processing Report

Experts share insights into analytical tools and techniques.

A Lukewarm Reception

July 2, 2012

Pharmaceutical Technology

Careful attention to detail will help to prevent valuable assets from "melting" away.

Placket–Burman Designs

July 2, 2012

Pharmaceutical Technology

Applying current principals to traditional factorial designs.

35th Anniversary Special: Breakthroughs and Emerging Technologies in Manufacturing

July 2, 2012

Pharmaceutical Technology

Industry experts share their insight on solid-dosage and sterile manufacturing.

35th Anniversary Special: The Today and Tomorrow of Process Analytical Technology

July 2, 2012

Pharmaceutical Technology

Industry experts share perspectives on analytical instrumentation, methods, and data analysis.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here